How to Read a Copper Peptide Serum Label (Without Getting Misled by the Percentage)

If you've shopped for a GHK-Cu (copper peptide) serum, you've probably noticed the percentage doing a lot of heavy lifting in the marketing. "1% GHK-Cu." "9% total peptide complex." Bigger numbers, bolder claims. The trouble is, that number is one of the easiest things on a label to make impressive without it actually meaning much. Here's how to read it properly.

The Number on the Bottle Isn't Always the Number in the Bottle

Copper tripeptide-1 is usually sold to formulators as a pre-diluted trade ingredient — commonly a 1% solution, where the active peptide is dissolved in water or a carrier at a fixed concentration before it ever reaches a serum. When a brand lists "1% GHK-Cu" on a product page, it's often referring to how much of that pre-diluted solution went into the formula — not how much pure, active peptide ends up in the bottle. Depending on how much of the solution was used, the actual active concentration could be a small fraction of the headline number.

This isn't necessarily dishonest — it's just an industry sourcing quirk that most shoppers aren't told about, and few brands go out of their way to explain the difference between "1% of a pre-diluted solution" and "1% pure active peptide." They read the same on a label, but they are not remotely the same product.

Why It Matters More for GHK-Cu Than Most Ingredients

Here's the part that makes this especially hard to check: the clinical trials most often cited for GHK-Cu's skin benefits — the ones testing real, finished copper-peptide creams over 12 weeks — don't publish the exact formulation percentage they used. It's treated as proprietary, the same way most cosmetic companies protect their formulas. So there's no single, published "target number" you can hold every serum up against. That's exactly why the pure-versus-diluted distinction above matters more than the number itself: without a public benchmark to compare to, a brand can lean on an impressive-looking diluted-solution percentage, and there's no way to tell from the number alone whether it's meaningful.

What to Actually Look For

A few questions can cut through most of the ambiguity when you're comparing copper peptide serums:

Does the listing specify "pure" or "active" concentration, or just a raw percentage with no context? A number without that qualifier is the one most likely to be a pre-diluted figure rather than the true active dose.

Does the brand explain how they're measuring the number, anywhere on the page? Most won't — but the ones that do are giving you something you can actually evaluate rather than just compare at face value.

Is the percentage in the high single digits or more? Pure, copper-bound peptide is unusual and comparatively expensive to formulate at high concentrations, so a very large number is more often describing the diluted trade solution than the active ingredient itself — though this is a general pattern, not a hard rule, so weigh it alongside the other questions above.

Bigger Isn't Automatically Better, Anyway

Even if a brand is reporting true active concentration, more GHK-Cu isn't a straightforward win. It's a peptide that works through cell signalling, not bulk delivery, so it doesn't behave like an ingredient where higher automatically means stronger results. A serum reporting a modest, precise, pure percentage is arguably a more credible formulation than one leading with a large, unexplained number — precision is the signal to look for, not size.

How We Report Ours

Our Renewal Serum is formulated at 0.2% pure copper tripeptide-1, and we say "pure" because we mean it: that's the active peptide concentration, not a pre-diluted solution percentage. We'd rather hand you a smaller, verifiable number than a bigger one you have no way to check.

For more on where GHK-Cu comes from and what the research actually shows, see our deep dive on copper peptide research, or the broader overview of topical peptides in skincare.

0 comments

Leave a comment

Please note, comments need to be approved before they are published.